EXACT THERAPEUTICS Oslo, May 31, 2023 -EXACT Therapeutics AS (Euronext Growth Oslo: EXTX), a clinical stage precision health company utilising Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas will participate at the ABGSC Life Science Summit today May 31, 2023.
EXACT CEO Per Walday will present the company and the unique technology behind ACT® at 14.00 CET.
The presentation will be available after the meeting on EXACT Therapeutics website; www.exact-tx.com.
About EXACT-Tx
EXACT-Tx is a clinical-stage Norwegian precision health company developing a technology platform for targeted therapeutic enhancement - Acoustic Cluster Therapy (ACT®). ACT® follows a unique approach to ultrasound-mediated, targeted drug enhancement - with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and brain diseases.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Exact Therapeutics ASA published this content on 31 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 May 2023 11:03:16 UTC.
